Pharma company Merrion lists on IEX

SHARES in Merrion Pharmaceuticals, the specialist pharmaceuticals company with operations in Ireland and the United States, began trading yesterday on IEX, the Irish Stock Exchange’s specialist market for small and medium-sized companies.

Coinciding with the listing, Merrion is raising €8m in new equity and will have a starting market capitalisation of €67.16m based on the issue price of €4.05 per share.

Merrion is the first company to seek an IEX-only listing and brings the number of firms on IEX to 30.